• Japanese
  • Korean
  • Chinese
Cover Image

Germ Cell Tumors Global Clinical Trials Review, H1, 2012

Abstract

Summary

GlobalData's clinical trial report, "Germ Cell Tumors Global Clinical Trials Review, H1, 2012" provides data on the Germ Cell Tumors clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Germ Cell Tumors. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Germ Cell Tumors. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Germ Cell Tumors Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Germ Cell Tumors , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Germ Cell Tumors
    • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials by Country
    • Top Countries Contributing to Clinical Trials in Asia-Pacific
    • Top Five Countries Contributing to Clinical Trials in Europe
    • Top Countries Contributing to Clinical Trials in North America
    • Top Countries Contributing to Clinical Trials in Middle East and Africa
    • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by BRIC Nations
  • Clinical Trials by G7 Nations
  • Clinical Trials in G7 Nations by Trial Status
  • Clinical Trials by E7 Nations
  • Clinical Trials in E7 Nations by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Germ Cell Tumors
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
    • Top Companies Participating in Germ Cell Tumors Therapeutics Clinical Trials
  • Prominent Drug Comparison
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
    • The EMMES Corporation
    • Clinical Trial Overview of The EMMES Corporation
    • Daiichi Sankyo, Inc.
    • Clinical Trial Overview of Daiichi Sankyo, Inc.
    • St. Jude Children's Research Hospital, Inc.
    • Clinical Trial Overview of St. Jude Children's Research Hospital, Inc.
    • ArQule, Inc.
    • Clinical Trial Overview of ArQule, Inc.
  • Clinical Trial Overview of Top Universities / Institutes / Hospitals
    • Memorial Sloan Kettering Cancer Center
    • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
    • Fred Hutchinson Cancer Research Center
    • Clinical Trial Overview of Fred Hutchinson Cancer Research Center
    • Indiana University School of Medicine
    • Clinical Trial Overview of Indiana University School of Medicine
    • Case Comprehensive Cancer Center
    • Clinical Trial Overview of Case Comprehensive Cancer Center
    • Federation Nationale des Centres de Lutte Contre le Cancer
    • Clinical Trial Overview of Federation Nationale des Centres de Lutte Contre le Cancer
    • The University of Texas M. D. Anderson Cancer Center
    • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
    • Dana-Farber Cancer Institute
    • Clinical Trial Overview of Dana-Farber Cancer Institute
    • Tel-Aviv Sourasky Medical Center
    • Clinical Trial Overview of Tel-Aviv Sourasky Medical Center
    • Duke University
    • Clinical Trial Overview of Duke University
    • Wake Forest University
    • Clinical Trial Overview of Wake Forest University
    • The University of Chicago
    • Clinical Trial Overview of The University of Chicago
    • Indiana University
    • Clinical Trial Overview of Indiana University
    • Mayo Clinic
    • Clinical Trial Overview of Mayo Clinic
    • Abramson Cancer Center
    • Clinical Trial Overview of Abramson Cancer Center
    • Masonic Cancer Center
    • Clinical Trial Overview of Masonic Cancer Center
    • OHSU Knight Cancer Institute
    • Clinical Trial Overview of OHSU Knight Cancer Institute
    • City of Hope National Medical Center
    • Clinical Trial Overview of City of Hope National Medical Center
    • Duke Comprehensive Cancer Center
    • Clinical Trial Overview of Duke Comprehensive Cancer Center
    • Children's Memorial Hospital
    • Clinical Trial Overview of Children's Memorial Hospital
    • Hannover Medical School
    • Clinical Trial Overview of Hannover Medical School
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Germ Cell Tumors Therapeutics Market, Global, Clinical Trials by Zone, 2012*
  • Germ Cell Tumors Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
  • Germ Cell Tumors Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, North America, Top Countries, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, BRIC Countries, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, G7 Countries, 2012*
  • Germ Cell Tumors Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, E7 Countries, 2012*
  • Germ Cell Tumors Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
  • Germ Cell Tumors Therapeutics Market, Global, Clinical Trials by Phase, 2012*
  • Germ Cell Tumors Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
  • Germ Cell Tumors Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
  • Germ Cell Tumors Therapeutics Market, Global, Suspended Clinical Trials, 2012*
  • Germ Cell Tumors Therapeutics Market, Global, Terminated Clinical Trials, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
  • Germ Cell Tumors Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by The EMMES Corporation, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo, Inc., 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Children's Research Hospital, Inc., 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by ArQule, Inc., 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University School of Medicine, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Federation Nationale des Centres de Lutte Contre le Cancer, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Dana-Farber Cancer Institute, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Tel-Aviv Sourasky Medical Center, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Wake Forest University, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Masonic Cancer Center, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by OHSU Knight Cancer Institute, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by City of Hope National Medical Center, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke Comprehensive Cancer Center, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Children's Memorial Hospital, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials Market, Global, Clinical Trials by Hannover Medical School, 2012*

List of Figures

  • Germ Cell Tumors Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
  • Germ Cell Tumors Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
  • Germ Cell Tumors Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, BRIC Countries (%), 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, G7 Countries (%), 2012*
  • Germ Cell Tumors Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, E7 Countries (%), 2012*
  • Germ Cell Tumors Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
  • Germ Cell Tumors Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
  • Germ Cell Tumors Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
  • Germ Cell Tumors Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
  • Germ Cell Tumors Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
  • Germ Cell Tumors Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
  • GlobalData Methodology
Show More
Pricing
Get Notified
Email me when related reports are published